VANCOUVER, May 21, 2020 /PRNewswire/ – Correvio Pharma Corp. (“Correvio” or the “Company“) (NASDAQ: CORV) (TSX: CORV), a specialty pharmaceutical company focused on commercializing hospital drugs, today announced that it has obtained a final order from the Supreme Court of British Columbia approving the previously announced […]

NASDAQ: CORV   TSX: CORV VANCOUVER, April 8, 2020 /PRNewswire/ – Correvio Pharma Corp. (“Correvio” or the “Company“) (NASDAQ: CORV) (TSX: CORV), a specialty pharmaceutical company focused on commercializing hospital drugs, today announced  that it has obtained an interim order from the Supreme Court of British Columbia (the “Court“) […]

ADVANZ PHARMA to Acquire Correvio in a Deal Valued at US$76 Million Correvio to Hold a Meeting of Its Securityholders by No Later than May 20, 2020 Transaction Expected to Close During the Second Quarter of 2020 NASDAQ: CORV  TSX: CORV VANCOUVER, March 30, […]

VANCOUVER, March 2, 2020 /PRNewswire/ – At the request of Investment Industry Regulatory Organization of Canada (“IIROC”), Correvio Pharma Corp. (NASDAQ: CORV) (TSX: CORV) (the “Company”) wishes to confirm that it is not aware of any material, undisclosed information related to the Company that would account […]

NASDAQ: CORV TSX: CORV VANCOUVER, Jan. 28, 2020 /PRNewswire/ – Correvio Pharma Corp. (Nasdaq: CORV) (TSX: CORV), (“Correvio” or the “Company”) announced today that it has received two written notifications from The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it is not in […]

NEW YORK–(BUSINESS WIRE)–Bragar Eagel & Squire, P.C., a nationally recognized shareholder law firm, announces that a class action lawsuit has been filed in the United States District Court for the Southern District of New York on behalf of investors that […]